5Martling A,Holm T,Johansson H,et al.The Stockholm Ⅱ trial on preoperative radiotherapy in vectal carcinoma:long-term follow-up of a population-based study[J].cancer,2001,92 (4):896-902.
3Jemal A, Murray T, Samuels A, et al. Cancer statistics 2003 [J]. CA Cancer J Clin,2003,53(1):5-26.
4Young J, Jenkins M, Parry S, et al. Serrated pathway colorectal cancer in the population: genetic consideration [J]. Gut, 2007, 56 (10): 1453-1459.
5Strate LL, Syngal S. Hereditary colorectal cancer syndromes [J]. Cancer Causes Control, 2005, 16 (3): 201-213.
6Siddiqui AA, Fayiga Y, Huerta S. The role of endoscopic ultrasound in the evaluation of rectal cancer[J]. Int Semin Surg Oncol, 2006, 3( 1 ): 36.
7Goldstein MJ, Mitchell EP.Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer [J]. Cancer Invest, 2005,23 (4): 338-351.
8Lahaye MJ, Engelen SM, Nelemans PJ, et al.lmaging for predicting the risk factors--the circumferential resection margin and nodal disease--of local recurrence in rectal cancer: a meta-analysis [J]. Semin Ultrasound CT MR, 2005, 26 (4): 259-268.
9Compton CC, Greene FL. The staging of colorectal cancer: 2004 and beyond[J]. CA Cancer J Clin, 2004,54 (6): 295-308.
10Schmidt CR, Gollub MJ, Weiser MR. Contemporary imaging for colorectal cancer [J]. Surg Oncol Clin N Am, 2007, 16 (2): 369-388.
